Pub Date : 2024-03-08DOI: 10.1007/s13206-024-00142-6
Yo-han Choi, Woo-Joong Kim, Dongwoo Lee, Bum-Joon Jung, Eui-Cheol Shin, Wonhee Lee
Among human CD8+ T cells, senescent cells are marked by the expression of CD57. The frequency of senescent CD57+CD8+ T cells is significantly correlated with aging and age-associated disorders, and it can be measured by multi-color flow cytometry. However, multi-color flow cytometry presents challenges in terms of accessibility and requires significant resource allocation. Therefore, developing a rapid and straightforward method for quantifying CD57+CD8+ T cells remains a key challenge. This study introduces a microfluidic device composed of a PDMS microfluidic channel with a pre-modified glass substrate for anti-CD8 antibody immobilization. This design allows blood samples to flow through, enabling the selective capture of CD8+ T cells while minimizing the required blood sample volume. This technology enables accurate and reliable quantification of CD57+ cells among captured CD8+ T cells through fluorescence image analysis. The ability of the device to easily quantify senescent CD57+CD8+ T cells is anticipated to contribute significantly to both immunological research and clinical applications.
在人类 CD8+ T 细胞中,衰老细胞以表达 CD57 为标志。衰老的 CD57+CD8+ T 细胞的频率与衰老和年龄相关疾病密切相关,可以通过多色流式细胞术测量。然而,多色流式细胞术在可及性方面存在挑战,并且需要大量的资源分配。因此,开发一种快速、直接的方法来量化 CD57+CD8+ T 细胞仍是一项关键挑战。本研究介绍了一种微流控装置,该装置由一个 PDMS 微流控通道和一个用于固定抗 CD8 抗体的预修饰玻璃基底组成。这种设计可使血液样本流过,从而选择性地捕获 CD8+ T 细胞,同时最大限度地减少所需的血液样本量。这项技术可通过荧光图像分析对捕获的 CD8+ T 细胞中的 CD57+ 细胞进行准确可靠的量化。该设备能够轻松量化衰老的 CD57+CD8+ T 细胞,预计将极大地促进免疫学研究和临床应用。
{"title":"Microfluidic Capture Device for Simple, Cell Surface Marker-Based Quantification of Senescent CD8+ T Cells","authors":"Yo-han Choi, Woo-Joong Kim, Dongwoo Lee, Bum-Joon Jung, Eui-Cheol Shin, Wonhee Lee","doi":"10.1007/s13206-024-00142-6","DOIUrl":"https://doi.org/10.1007/s13206-024-00142-6","url":null,"abstract":"<p>Among human CD8<sup>+</sup> T cells, senescent cells are marked by the expression of CD57. The frequency of senescent CD57<sup>+</sup>CD8<sup>+</sup> T cells is significantly correlated with aging and age-associated disorders, and it can be measured by multi-color flow cytometry. However, multi-color flow cytometry presents challenges in terms of accessibility and requires significant resource allocation. Therefore, developing a rapid and straightforward method for quantifying CD57<sup>+</sup>CD8<sup>+</sup> T cells remains a key challenge. This study introduces a microfluidic device composed of a PDMS microfluidic channel with a pre-modified glass substrate for anti-CD8 antibody immobilization. This design allows blood samples to flow through, enabling the selective capture of CD8<sup>+</sup> T cells while minimizing the required blood sample volume. This technology enables accurate and reliable quantification of CD57<sup>+</sup> cells among captured CD8<sup>+</sup> T cells through fluorescence image analysis. The ability of the device to easily quantify senescent CD57<sup>+</sup>CD8<sup>+</sup> T cells is anticipated to contribute significantly to both immunological research and clinical applications.</p>","PeriodicalId":8768,"journal":{"name":"BioChip Journal","volume":"82 1","pages":""},"PeriodicalIF":4.3,"publicationDate":"2024-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140070306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-21DOI: 10.1007/s13206-024-00139-1
Ji-Hong Bong, Soo Jeong Lee, Jaeyong Jung, Jeong Soo Sung, Min-Jung Kang, Misu Lee, Joachim Jose, Jae-Chul Pyun
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid protein (NP) participates in viral genome packaging and abundantly produced when infected. In this work, SPR biosensor for the detection of SARS-CoV-2 in viral fluid using Fv-antibodies with the binding affinity to nucleocapsid protein (NP) of SARS-CoV-2. The FV-antibodies with a specific binding activity to the SARS-CoV-2 NP were screened using the FV-antibody library, which was expressed on the outer membrane of E. coli. FV-antibodies comprised three complementarity-determining regions (CDRs) and four frame regions (FRs) of the heavy chain at the binding pocket of IgG. The FV-antibody library was prepared by performing site-directed mutagenesis and by using the autodisplay technology; FV-antibodies with specific binding activities to the nucleocapsid protein (NP) of SARS-CoV-2 were screened using NP-immobilized magnetic beads. First, E. coli isolates with the target FV-antibody were screened, and the binding affinity (KD) was estimated for the screened E. coli clones using FACS analysis. Then, the outer membrane (OM) of the screened E. coli clones with autodisplayed Fv-antibodies was obtained and layered on an SPR biosensor, and the binding curves of four different coronavirus (CoV) culture fluids, SARS-CoV-2, SARS-CoV, MERS-CoV, and CoV strain 229E, were compared. Finally, the FV-antibodies of the screened E. coli clones were synthesized as peptides (11 amino acid residues), and the binding constants (KD) to NP as well as the binding curves of the CoV strains in culture fluids were estimated. Using docking simulation, binding sites and interaction types between NP and each synthetic peptide were investigated.